Artificial Pancreas | Page 2 of 4

Biodel Receives NIH Grant to Develop Glucagon Formulations For Artificial Pancreas

The Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH) has awarded Biodel Inc. a grant for the development of novel and stable glucagon formulations for use in an artificial pancreas, also known as a closed loop pump system. The SBIR program is a highly competitive program that encourages domestic small businesses to engage in Federal Research/Research and Development that has the potential for commercialization.

Positive Results for First-Generation Artificial Pancreas System

Positive results from the first feasibility study of an advanced first-generation artificial pancreas system were presented at the 72nd Annual American Diabetes Association Meeting in Philadelphia. Findings from the study indicated that the Hypoglycemia-Hyperglycemia Minimizer (HHM) System...

Dexcom to Develop a “Smart Transmitter” as Part of JDRF Artificial Pancreas Project

JDRF and Dexcom announced that they have formed a partnership whose goal is to accelerate the development of a novel wireless “smart transmitter” that would allow a continuous glucose monitor (CGM) system to communicate directly with an artificial pancreas...

First US Artificial Pancreas Outpatient Trial Approved by FDA

The U.S. Food and Drug Administration (FDA) has approved the first outpatient artificial pancreas trial in the United States, marking a critical development in the effort by JDRF and its allies to bring this innovative and lifesaving diabetes technology to people with type 1 diabetes...

FDA Issues Draft Guidance for the Development and Approval of the Artificial Pancreas

The U.S. Food and Drug Administration (FDA) issued draft guidance designed to help investigators and manufacturers as they develop and seek approval for artificial pancreas device systems to treat type 1 diabetes. This step comes after a large campaign led by the Juvenile Diabetes research Foundation ...

The Loop Has Closed: The Artificial Pancreas Program Comes to Life in Israel

Diabetes technology has vastly improved in the last decade, and most people with diabetes who have the opportunity to wear an insulin pump or a continuous glucose monitor are grateful for the assistance they provide. But even with these advanced tools, the biggest burdens of diabetes - the insulin dosing and blood sugar testing - still lie on the person with diabetes or a caregiver.

Artificial Pancreas Provides Better Nighttime Blood Sugar Control Than the Pump

The artificial pancreas is better at controlling night time blood sugar levels than conventional pump therapy according to two knew studies carried out at the Wellcome Trust clinical research facility at Addenbrooke’s Hospital in England....

Artificial Pancreas May Drastically Reduce Complications in Type 1 Diabetes Pregnancy

New research, funded by Diabetes UK, has found that use of an artificial pancreas by woman suffering from type 1 diabetes during pregnancy may drastically reduce cases of stillbirth and mortality rates...

New Recommendations For Artificial Pancreas Development

A panel of experts convened by the FDA and NIH to try to advance research and development of the artificial pancreas put forth clinical recommendations to ensure the safe and effective testing of artificial pancreas technology in real-life situations. The experts are in agreement that even with the advanced treatments available today...

Wireless CGM Sensor – A Milestone on the Way to an Artificial Pancreas

Researchers from the University of California San Diego and GlySens Inc. have developed an implantable sensor that measures blood sugar continuously and transmits the information without wires, according to a Reuters report . The device worked in one pig for more than a year and in another for nearly 10 months with no trouble, and the researchers hope to start a human study within a few months...